| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 07/02/2009 | US20090169524 Composites and methods of preparation and use thereof |
| 07/02/2009 | CA2710116A1 Preparations with rosehip extracts, and method of producing rosehip extracts |
| 07/02/2009 | CA2710081A1 Human bone-forming cells in the treatment of inflammatory rheumatic diseases |
| 07/02/2009 | CA2709530A1 Monosebacate of pyrazole derivative |
| 07/02/2009 | CA2707447A1 Sulfonyl-substituted 6-membered ring derivative |
| 07/01/2009 | EP2075258A1 Antibody against rgd in amino acid sequence of extracellular matrix protein and production method and use of the same |
| 07/01/2009 | EP2075002A2 Use of myoblasts in the manufacture of a medicament for treating stress urinary incontinence |
| 07/01/2009 | EP2074995A1 (+)-2-[1-(3-Ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione: methods of using and compositions thereof |
| 07/01/2009 | EP2074127A1 Pyrazolo [1, 5-a]pyrimidine derivatives and their therapeutic use |
| 07/01/2009 | EP2074115A1 N3-heteroaryl substituted triazoles and n5-heteroaryl substituted triazoles useful as axl inhibitors |
| 07/01/2009 | EP1784173A4 Pharmaceutical composition for preventing and treating metabolic bone diseases containing alpha-arylmethoxyacrylate derivatives |
| 07/01/2009 | EP1537075B1 Diarylurea derivatives and their use as chloride channel blockers |
| 07/01/2009 | EP1471054B1 Amino alcohol derivative or phosphonic acid derivative and medicinal composition containing these |
| 07/01/2009 | EP1414428B1 Histone deacetylase enzyme-inhibiting derivatives of hydroxamic acid as new cytokine synthesis-inhibiting anti-inflammatory drugs |
| 07/01/2009 | EP1248602B1 Use of retinoid receptor antagonists in the treatment of cartilage and bone pathologies |
| 07/01/2009 | CN101469329A Compositions and methods for increasing bone mineralization |
| 07/01/2009 | CN100506846C Selected antibodies and duramycin peptides binding to anionic phospholipids and aminophospholipids and their use in treating viral infections and cancer |
| 07/01/2009 | CN100506845C IFNAR2 mutants, their production and use |
| 07/01/2009 | CN100506844C Novel peptides |
| 07/01/2009 | CN100506831C Phosphonic acid compounds as inhibitors of serine proteases |
| 07/01/2009 | CN100506815C Piperidinyl targeting compounds that selectively bind integrins |
| 07/01/2009 | CN100506793C Vitamin D* lactam derivative |
| 07/01/2009 | CN100506277C Combinations of antibodies selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and other therapeutic agents |
| 07/01/2009 | CN100506249C Plaster for treating knocks and falls, and osteopathia |
| 06/30/2009 | US7553966 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 06/30/2009 | US7553918 pH-sensitive polymer |
| 06/30/2009 | US7553867 Furan or thiophene derivative and medicinal use thereof |
| 06/30/2009 | US7553852 Caspase inhibitors and uses thereof |
| 06/30/2009 | US7553845 1-Methoxy-3-(3-methoxy-4-nitrobenzoyl)-2-methylindolizin-6-yl]carboxamide; angiogenesis inhibitors; antitumor, -carcinogenic, and metastasis agent; rheumatic diseases; antiarthritic agents; atherosclerosis; retenosis; leukemia; cardiotonic agents; imflammatory bowel disease; obesity; antidiabetic agents |
| 06/30/2009 | US7553500 6-phenyl-5-(4-(2-pyrrolidin-1-ylethoxy)phenyl)-5,6,7,8 -tetrahydronaphthalen-2-ol (laxofoxifene); a prodrug with a glidant, disintegrant, lubricant and diluent/filler in given amounts; unit dosage forms, including low dosage forms; selective estrogen receptor modulators |
| 06/30/2009 | US7553492 Gene overexpression/underexpression; antibodies; drug screening; kits |
| 06/30/2009 | US7553488 Chemokine inhibitors; for treatment of gout; for inhibiting migration of neutrophils involved in pathogenesis |
| 06/30/2009 | US7553482 Preventing atherosclerotic disease, bone disorders by administering iron(III) oxide hydroxide-carbohydrate complexes; for reducing the calcium phosphate product, calcium level in the blood; side effect reduction; controlling blood metal concentration |
| 06/30/2009 | CA2359874C Method for reducing hip joint laxity |
| 06/30/2009 | CA2307111C Novel pyridazine derivatives and drugs containing the same as the active ingredient |
| 06/25/2009 | WO2009079585A2 Compositions and methods for treating osteolytic disorders comprising mmp-14 binding proteins |
| 06/25/2009 | WO2009079471A1 Method for treating bone fracture with anti-sclerostin antibodies |
| 06/25/2009 | WO2009079007A1 Stem-like cells and method for reprogramming adult mammalian somatic cells |
| 06/25/2009 | WO2009078796A1 Compositions and methods for treatment of autoimmune and allergic diseases |
| 06/25/2009 | WO2009078445A1 Pharmaceutical preparation |
| 06/25/2009 | WO2009077585A1 N-aryl-n-piperidin-4-yl-propionamide derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 06/25/2009 | WO2009077334A1 Novel imidazo[1,2-a]pyridine and imidazo[1,2-b]pyridazine derivatives |
| 06/25/2009 | WO2009052200A3 Human adam-10 inhibitors |
| 06/25/2009 | WO2009009122A3 Derivatives of urea and related diamines, methods for their manufacture, and uses therefor |
| 06/25/2009 | US20090163593 Phenylalkylene-substituted or allyloxyphenylmethyl-substituted, e.g., N-(p-allyloxybenzyl-N-(2-methoxyethyl)-N-(3-phenylallyl)amine; endocannabinoid agonists; pain, Parkinson's disease, multiple sclerosis, or Huntington's chorea; asthma |
| 06/25/2009 | US20090163590 Process for producing refined avocado oil rich in triglycerides, and oil obtainable by said process |
| 06/25/2009 | US20090163580 Anti-aging composition containing resveratrol and method of administration |
| 06/25/2009 | US20090163556 Glycinamide derivatives as raf-kinase inhbitors |
| 06/25/2009 | US20090163535 Substituted Heteroarylalkanoic Acids |
| 06/25/2009 | US20090163515 Compounds Which Bind to the Active Site of Protein Kinase Enzymes |
| 06/25/2009 | US20090163497 Compounds Useful as Antagonists of CCR2 |
| 06/25/2009 | US20090163495 Morpholin-acetamide derivatives for the treatment of inflammatory diseases |
| 06/25/2009 | US20090163493 cell proliferation, such as cancer, inflammation, and angiogenesis; fungal infections; antimalaria; Heat hock protein 90 (HSP-90) inhibitor |
| 06/25/2009 | US20090163468 Fused Bicyclic mTor Inhibitors |
| 06/25/2009 | US20090163463 Organic Compounds |
| 06/25/2009 | US20090163440 Ion-Channel Regulator Compositions and Methods of Using Same |
| 06/25/2009 | US20090162452 EB Matrix Production From Animal Tissue And Its Use For Tissue Repair |
| 06/25/2009 | US20090162436 Compositions and methods for repair of tissues |
| 06/25/2009 | US20090162351 Transdiscal administration of inhibitors of p38 MAP kinase |
| 06/25/2009 | US20090162346 determining increased risk for developing positive autoantibody rheumatoid factor (RF+) Rheumatoid Arthritis (RA) in human by testing nucleic acid from the human to detect the nucleotide content of a single nucleotide polymorphism (SNP) at position 101 of SEQ ID NOS:526, 92-525, and 527-584 |
| 06/25/2009 | US20090162328 In vivo assay and molecular markers for testing the phenotypic stability of cell populations and selected cell populations for autologous transplantation |
| 06/25/2009 | US20090162282 Substituted 4--piperidine-1-carboxylic acid esters as a2ar agonists |
| 06/25/2009 | CA2708361A1 Novel imidazo[1,2-a]pyridine and imidazo[1,2-b]pyridazine derivatives |
| 06/25/2009 | CA2707637A1 Compositions and methods for treating osteolytic disorders comprising mmp-14 binding proteins |
| 06/24/2009 | EP2072522A1 Thioglucose spiroketal derivative and use thereof as therapeutic agent for diabetes |
| 06/24/2009 | EP2072519A1 Diaryl ketimine derivative |
| 06/24/2009 | EP2072046A1 Use of a hydrocarbon-containing preparation for preventing or treating cardiac-circulatory diseases, diabetes, osteoporosis and chronic liver failure |
| 06/24/2009 | EP1951261A4 Compositions and methods for treating inflammatory disorders |
| 06/24/2009 | EP1499746A4 Method to inhibit cell growth using oligonucleotides |
| 06/24/2009 | EP1445258B1 Activator for peroxisome proliferator-activated receptor delta |
| 06/24/2009 | EP1339709B1 Farnesyl transferase inhibiting benzoheterocyclic derivatives |
| 06/24/2009 | EP1284977B1 Thienodibenzoazulene compounds as tumor necrosis factor inhibitors |
| 06/24/2009 | EP1152761B1 Use of 5-ht3 receptor antagonists for treating musculoeskeletal diseases |
| 06/24/2009 | CN100503608C Deazapurines and uses thereof |
| 06/24/2009 | CN100503602C Benzopyran derivatives substituted with secondary amines including tetrazole, method for the preparation thereof and pharmaceutical compositions containing them |
| 06/24/2009 | CN100503599C Carbonylamino-derivatives as novel inhibitors of histone deacetylase |
| 06/24/2009 | CN100503574C Substituted ideno[1,2-c]isoquinoline derivatives and methods of use thereof |
| 06/24/2009 | CN100503572C Caspase inhibitors and uses thereof |
| 06/24/2009 | CN100503566C Inhibitors of cytosolic phospholipase A2 |
| 06/24/2009 | CN100502915C Chinese medicinal herb capsule for treating hyperosteogeny |
| 06/24/2009 | CN100502888C Lipoteichoic acid from lactic acid bacteria and its use to modulate immune responses mediated by gram-negative, potentially pathogenic gram-positive bacteria |
| 06/24/2009 | CN100502863C 2,4,5-trisubstituded thiazolyl derivatives and their anti-inflammatory activity |
| 06/23/2009 | US7550503 Macrolide compounds comprising 18,19-epoxytricosa-8,12,14-trien-11-olide derivatives; angiogenesis inhibitors; anticarcinogenic, antimetastasis, antiinflammatory, and antitumor agents; antihypoxic agents; endothelial growth factor suppressors; retinal neovascularization, diabetic retinopathy |
| 06/23/2009 | US7550489 N-[3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-2-(5-trifluoromethyl-2-pyridyloxy)-2-methylpropanamide and phentermine, metformin, or bupropion; obesity; antipsychotic agents; synergistic; cannabinoid receptor antagonists |
| 06/23/2009 | US7550476 Condensed polycyclic compounds |
| 06/23/2009 | US7550475 Use of phosphodiesterase 4 inhibitors such as 6,7-dimethoxy-1-[2-(1,3-dioxocyclohexan-2-yl)pyridin-4-yl]-2,3-bis(hydroxymethyl)naphthalene to treat asthma, chronic obstructive pulmonary disease, atopic dermatitis, allergic rhinitis, psoriasis, rheumatoid arthritis, septic shock, ulcerative colitis |
| 06/23/2009 | US7550470 Substituted pyrazolo[1,5-A]pyrimidines as tyrosine kinase inhibitors |
| 06/23/2009 | US7550464 Use of phosphodiesterase 4 inhibitors such as 8,9-dimethoxy-6-phenyl-1,3,4,6,11,11a-hexahydro-2H -pyrazino[1,2-b]isoquinoline for treating asthma, chronic obstructive pulmonary disease, atopic dermatitis, allergic rhinitis, psoriasis, rheumatoid arthritis, septic shock, ulcerative colitis |
| 06/23/2009 | US7550159 For treatment of cancer and autoimmune diseases; kits |
| 06/23/2009 | CA2492804C Novel inhibitors of kinases |
| 06/23/2009 | CA2389219C Dry powder compositions having improved dispersivity |
| 06/23/2009 | CA2252535C A pharmaceutical formulation containing growth hormone, an amino acid and a non-ionic detergent |
| 06/18/2009 | WO2009076512A1 Carboxamidξ compounds and their use as chemokine receptor agonists |
| 06/18/2009 | WO2009076404A1 Carboxamide compounds and their use as antagonists of the chemokine ccr2 receptor |
| 06/18/2009 | WO2009075836A2 Rap variants for drug delivery |
| 06/18/2009 | WO2009075790A1 Metalloprotease inhibitors for intra-articular application |
| 06/18/2009 | WO2009075782A1 Methods useful for the treatment of pain, arthritic conditions, or inflammation associated with a chronic condition |
| 06/18/2009 | WO2009075349A1 Element retained in blood showing degradability selectively in tumor tissue |
| 06/18/2009 | WO2009075258A1 Transdermally absorptive preparation |
| 06/18/2009 | WO2009074644A1 Compositions comprising hydroxytyrosol and chondroitin and use thereof for the treatment, co-treatment or prevention of inflammatory disorders |